Physical Activity and Social Support Prompting Via Phone Messaging
8. mars 2017 oppdatert av: Shinyi Wu, University of Southern California
Phone Messaging for Physical Activity and Social Support Prompting Among Low-Income Latino Patients: A Randomized Pilot Study
The objective of this study was to investigate the feasibility, perceived usefulness, and potential effectiveness of a short text or voice message intervention to activate 1) physical activity behavior change among low-income, urban, Latino patients in diabetes management and 2) supportive behaviors by family members or close friends.
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Despite the promise of phone-based interventions to effectively support diabetes self-management (DSM), little is known about their impact on the outcomes of highly vulnerable populations such as low-income, inner-city, racial/ethnic minorities.
And while phone-based interventions have generally been successful at reaching and engaging adults with diabetes, they have failed to do the same with family members/friends (FF) whom are a promising source of ongoing support for DSM.
The objective of this study was to investigate the feasibility, perceived usefulness, and potential effectiveness of a short text or voice message (ST/VM) intervention to activate 1) physical activity (PA) behavior change among low-income, urban, Latino patients in diabetes management and 2) supportive behaviors by FF.
The investigators conducted a 12-week pilot study in which participants were randomized into one of three study arms: control, phone messaging (PM), and phone messaging plus social support from FF (PM+FF).
Participants were recruited in person from a diabetes management program at a safety-net ambulatory care clinic.
All participants were given a pedometer and walking log for self-monitoring.
Participants in the PM and PM+FF arms received ST/VMs as reminders to review daily step goals and to self-monitor; explaining the benefits of regular PA, importance of regular PA to daily life, and ways to overcome commonly identified barriers to PA; asking participants to report on PA performance; providing feedback based on responses.
Participants in the PM+FF identified a FF to receive ST/VMs with suggested behaviors that are perceived as supportive by individuals making PA behavior changes.
Participants received semi-structured assessments in person at baseline, 6 weeks, and 12 weeks.
Participants were asked about the extent to which the program enhanced the participant's ability to make PA behavior changes.
The primary outcome measures were daily step counts and perceived FF social support.
Studietype
Intervensjonell
Registrering (Faktiske)
42
Fase
- Ikke aktuelt
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
18 år og eldre (Voksen, Eldre voksen)
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
- Age greater than or equal to 18 years
- Diagnosis of type 2 diabetes
- No medical conditions restricting patient from beginning a walking program
- Preferred language of English or Spanish, self-identifies as a Hispanic
- Ability to walk without the use of assistive devices such as canes or walkers
- Available to attend three interviews at the clinic
- Does not plan to move away from the region or be out of the country during the next three months
- Has a working phone where they can receive regular short text or voice messages for three months
Exclusion Criteria:
- Pregnant or breastfeeding women
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Annen: Control
Pedometers and walking logs
|
Participants were recommended to use the pedometer and walking log to self-monitor how many steps participants walked each day.
Participants were recommended to gradually increase daily steps over the course of 12 weeks until reaching 10,000 steps per day.
Participants were also recommended to walk at a brisk pace for 3000 of these steps, which roughly translates to 30 minutes per day.
|
|
Eksperimentell: Phone Messaging
|
Participants were recommended to use the pedometer and walking log to self-monitor how many steps participants walked each day.
Participants were recommended to gradually increase daily steps over the course of 12 weeks until reaching 10,000 steps per day.
Participants were also recommended to walk at a brisk pace for 3000 of these steps, which roughly translates to 30 minutes per day.
Participants received short text or voice messages (depending on participant preference) as reminders to review daily step goals and to self-monitor; explaining the benefits of regular physical activity, importance of regular physical activity to daily life, and ways to overcome commonly identified barriers to physical activity; asking participants to report on their physical activity performance; providing feedback based on responses.
|
|
Eksperimentell: Phone Messaging + Family/Friend Support
|
Participants were recommended to use the pedometer and walking log to self-monitor how many steps participants walked each day.
Participants were recommended to gradually increase daily steps over the course of 12 weeks until reaching 10,000 steps per day.
Participants were also recommended to walk at a brisk pace for 3000 of these steps, which roughly translates to 30 minutes per day.
Participants received short text or voice messages (depending on participant preference) as reminders to review daily step goals and to self-monitor; explaining the benefits of regular physical activity, importance of regular physical activity to daily life, and ways to overcome commonly identified barriers to physical activity; asking participants to report on their physical activity performance; providing feedback based on responses.
Participants identified a family member or close friend (FF) to receive short text or voice messages (depending on FF preference) with suggested behaviors that are perceived as supportive by individuals making physical activity behavior changes.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in average daily steps assessed by pedometers
Tidsramme: Baseline, 6 weeks, 12 weeks
|
Change in average daily steps assessed using pedometer 7-day data storage
|
Baseline, 6 weeks, 12 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in body mass index
Tidsramme: Baseline, 6 weeks, 12 weeks
|
Change in Body Mass Index, which was calculated as weight (in kilograms) over height squared (in centimeters)
|
Baseline, 6 weeks, 12 weeks
|
|
Change in exercise self-efficacy assessed using the Exercise Self-Efficacy Scale
Tidsramme: Baseline, 6 weeks, 12 weeks
|
Change in exercise self-efficacy assessed using the Exercise Self-Efficacy Scale
|
Baseline, 6 weeks, 12 weeks
|
|
Change in barriers self-efficacy assessed using the Barriers Self-Efficacy Scale
Tidsramme: Baseline, 6 weeks, 12 weeks
|
Change in barriers self-efficacy assessed using the Barriers Self-Efficacy Scale
|
Baseline, 6 weeks, 12 weeks
|
|
Change in perceived family/friend social support assessed using the Social Support and Exercise Survey
Tidsramme: Baseline, 6 weeks, 12 weeks
|
Change in perceived family/friend social support assessed using the Social Support and Exercise Survey
|
Baseline, 6 weeks, 12 weeks
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in perceived usefulness assessed using patient interviews
Tidsramme: 6 weeks, 12 weeks
|
At the 6- and 12-week follow-up interviews, participants were asked a series of unstructured questions regarding the extent to which the program enhanced a participant's ability to make physical activity behavior changes.
These questions inquired about participants' thoughts on setting PA goals, self-monitoring, educational and feedback ST/VMs, and the idea of using ST/VMs to communicate with patients about PA behavior change.
For participants in the PM+FF arms, the questions also inquired about supportive behaviors exhibited by FF since the start of the program and participants' thoughts on the idea of using ST/VMs to communicate with FF about patients' PA behavior changes.
Investigators also asked if participants would be willing to participate in a similar program in the future and if participants would be willing to recommend the program to other patients.
The latter two were yes/no questions.
|
6 weeks, 12 weeks
|
|
Change in perceived usability of pedometers assessed via patient interviews
Tidsramme: Baseline, 6 weeks, 12 weeks
|
Semi-structured patient interview questions inquiring about the degree to which participants perceived the pedometers to be easy to use
|
Baseline, 6 weeks, 12 weeks
|
|
Change in perceived barriers to receipt of and engagement with ST/VMs assessed via patient interviews
Tidsramme: 6 weeks, 12 weeks
|
Semi-structured patient interview questions inquiring about participants' perceived barriers to the receipt of and engagement with ST/VMs
|
6 weeks, 12 weeks
|
|
Change in engagement with ST/VMs requiring a response assessed via call logs
Tidsramme: 6 weeks, 12 weeks
|
Percentage of times that participants responded to ST/VMs requiring a response
|
6 weeks, 12 weeks
|
|
Change in receipt of ST/VMs assessed via self-report and call logs
Tidsramme: 6 weeks, 12 weeks
|
Percentage of short text messages delivered that were received assessed via self-report, and percentage of voice messages that were received assessed via call logs
|
6 weeks, 12 weeks
|
|
Change in non-compliance with wearing pedometer assessed via pedometer and walking log
Tidsramme: Baseline, 6 weeks, 12 weeks
|
Percentage of patients that did not wear the pedometer for a minimum of three consecutive days for at least 10 hours per day.
This data will be obtained using the pedometer 7-day memory storage and participants' self-reported hours of use.
|
Baseline, 6 weeks, 12 weeks
|
|
Recruitment and retention rates assessed via recruitment and follow-up logs
Tidsramme: 1 day (Recruitment), 6 weeks, 12 weeks
|
Percentage of patients that were screened, were eligible to participate, and enrolled in the study.
Percentage of patients who completed the 6-week and 12-week follow-up assessments.
|
1 day (Recruitment), 6 weeks, 12 weeks
|
|
Sufficiency or restrictiveness of eligibility criteria assessed via recruitment logs
Tidsramme: 1 day (Recruitment)
|
Percentage of patients that were screened, but were ineligible to participate and the reasons why
|
1 day (Recruitment)
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Shinyi Wu, Ph.D., University of Southern California
Publikasjoner og nyttige lenker
Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart
1. april 2015
Primær fullføring (Faktiske)
1. november 2015
Studiet fullført (Faktiske)
1. november 2015
Datoer for studieregistrering
Først innsendt
12. april 2016
Først innsendt som oppfylte QC-kriteriene
29. juli 2016
Først lagt ut (Anslag)
1. august 2016
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
13. mars 2017
Siste oppdatering sendt inn som oppfylte QC-kriteriene
8. mars 2017
Sist bekreftet
1. mars 2017
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- HS-13-00471
- 3U54NS081764-03S1 (U.S. NIH-stipend/kontrakt)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
UBESLUTTE
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .